ZM-241,385

ZM-241,385
IUPAC ime
Identifikacija
CAS registarski broj 139180-30-6 DaY
PubChem[1][2] 176407
ChemSpider[3] 153646 DaY
ChEMBL[4] CHEMBL1628689 DaY
IUPHAR ligand 405
Jmol-3D slike Slika 1
Svojstva
Molekulska formula C16H15N7O2
Molarna masa 337.34 g mol−1

 DaY (šta je ovo?)   (verifikuj)

Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala

Infobox references

ZM-241,385 je antagonist visokog afiniteta koji je selektivan za adenosinski A2A receptor.[5]

U životinjskim modelima je pokazano da ZM-241,385 pruža zaštitu protiv beta amiloidne neurotoksičnosti i da stoga može da bude koristan u tretmanu Alchajmerove bolesti.[6]ZM-241,385 isto tako povećava otpuštanje dopamina izvedenog iz L-DOPA i stoga je koristan u tretmanu Parkinsonove bolesti.[7]

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Palmer TM, Poucher SM, Jacobson KA, Stiles GL (December 1995). 125I-4-(2-(7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5) triazin-5-yl-amino)ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor”. Molecular Pharmacology 48 (6): 970-4. PMID 8848012. Arhivirano iz originala na datum 2008-09-07. Pristupljeno 2014-04-11. 
  6. Dall'Igna OP, Porciúncula LO, Souza DO, Cunha RA, Lara DR, Dall'lgna OP (April 2003). „Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity”. British Journal of Pharmacology 138 (7): 1207-9. DOI:10.1038/sj.bjp.0705185. PMC 1573785. PMID 12711619. 
  7. Gołembiowska K, Dziubina A (September 2004). „Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats”. Neuropharmacology 47 (3): 414-26. DOI:10.1016/j.neuropharm.2004.04.018. PMID 15275831. 

Spoljašnje veze

[uredi | uredi kod]

MeSH ZM+241385